Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CellectGen, Inc. logo — Creating solutions that make early detection of disease a sn...

CellectGen, Inc.

Creating solutions that make early detection of disease a snap

Founded 2018 United States Pasadena, United States 4 employees

General Information

Company Name CellectGen, Inc.
Founded Year 2018
Location United States Pasadena, United States +1
Employees 4
Social

Get notified when CellectGen, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CellectGen, Inc.

CellectGen, Inc. is a pioneering startup with a mission to revolutionize disease detection. Their slogan, "Creating solutions that make early detection of disease a snap," embodies their commitment to providing user-friendly, saliva-based POC platform technologies. The company aims to assist dentists in identifying patients with a high risk of emerging active disease lesions in under 15 minutes, with a screening test as simple as 1-2-3. This innovative technology comprises integrated components including saliva collection, lateral flow-based tests, and a mobile application for real-time result quantification and treatment guidance. The potential impact of CellectGen, Inc. is immense, with a focus on improving early detection and prevention of dental implant failure and gum disease for the 64.7 million individuals affected by these conditions. Founded in 2018 and headquartered in the United States, the company's disruptive approach to disease detection presents an attractive opportunity for investors seeking to support groundbreaking healthcare solutions. With an emphasis on accessibility, accuracy, and cost-effectiveness, CellectGen, Inc. stands at the forefront of innovative healthcare technologies, poised to make a significant impact in the industry.

Taxonomy: Saliva-based POC platform, Early disease detection, Point-of-care testing technology, Biomarker detection, Mobile health technology, Dental health technology, Preventive healthcare, Digital health trends, Dental implant technology, Gum disease prevention

No funding data available for CellectGen, Inc. yet.

Get notified when CellectGen, Inc. raises funding

CellectGen, Inc. Alternatives & Competitors

CellectGen, Inc. vs
CaviSense
CaviSense United States

CaviSense is innovating early stage caries detection. Catch Cavities Early with CaviSense!

5 employees
Health Care, Medical Devices
CellectGen, Inc. vs
Caption Care
Caption Care

Turnkey Echo Program for Early Heart Disease Detection

1 employees
Health Care
CellectGen, Inc. vs
Biological Dynamics
Biological Dynamics

Advancing global health by detecting diseases at their earliest stages with proprietary biomarker te...

Grant
Biotechnology, Health Care

FAQ About CellectGen, Inc.

Creating solutions that make early detection of disease a snap
CellectGen, Inc. was founded in 2018.
CellectGen, Inc. is headquartered in Pasadena, United States.
CellectGen, Inc. has approximately 4 employees.
Top alternatives and competitors to CellectGen, Inc. include CaviSense, Caption Care, Biological Dynamics, LifeQ, Inc., Larkai Healthcare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CellectGen, Inc. and CaviSense are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CellectGen, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy